As Trump hails launch of COVID19 vaccines, makers of dry ice and related machines in China working in full swing to respond to soaring demand for cold chain, with some firms’ orders from US up 10-20 times y-o-y.
The ultra-cold temperatures required for storing the Covid-19 vaccine developed by U.S. pharmaceutical giant Pfizer and Germany-based BioNTech has driven a buying frenzy for freezers and dry ice. However, large-scale freezers units are expensive — and with hospital budgets already strained during the pandemic, dry ice has emerged as the go-to option. Thank you, Trump!
